Paul J. Mellett

2021

In 2021, Paul J. Mellett earned a total compensation of $1.9M as Senior Vice President, Finance & Administration, Chief Financial Officer at Enanta Pharmaceuticals, a 6% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$192,803
Option Awards$652,535
Salary$440,381
Stock Awards$582,640
Other$19,211
Total$1,887,570

Mellett received $652.5K in option awards, accounting for 35% of the total pay in 2021.

Mellett also received $192.8K in non-equity incentive plan, $440.4K in salary, $582.6K in stock awards and $19.2K in other compensation.

Rankings

In 2021, Paul J. Mellett's compensation ranked 6,263rd out of 12,397 executives tracked by ExecPay. In other words, Mellett earned more than 49.5% of executives.

ClassificationRankingPercentile
All
6,263
out of 12,397
50th
Division
Manufacturing
2,660
out of 5,492
52nd
Major group
Chemicals And Allied Products
1,166
out of 2,367
51st
Industry group
Drugs
1,038
out of 2,090
50th
Industry
Pharmaceutical Preparations
750
out of 1,537
51st

Pay ratio

Paul J. Mellett's Pay$1,887,570
Median Employee's Pay$230,731
Pay Ratio

8

to 1

In 2021, the annual total compensation of Paul J. Mellett was $1,887,570.

The annual total compensation of the median employee at Enanta Pharmaceuticals was $230,731.

The ratio of Paul J. Mellett's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on January 21, 2022.

Mellett's colleagues

We found five more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2021.

2021

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2021

Brendan Luu

Enanta Pharmaceuticals

Senior Vice President, Business Development

2021

Tara Kieffer

Enanta Pharmaceuticals

Senior Vice President, New Product Strategy & Development

2021

Yat Or

Enanta Pharmaceuticals

Chief Scientific Officer

2021

Nathaniel Gardiner

Enanta Pharmaceuticals

General Counsel

News

You may also like